OTCMKTS:THERF - Theratechnologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $6.4918 +0.22 (+3.51 %) (As of 12/16/2018 04:00 PM ET)Previous Close$6.4918Today's Range$6.30 - $6.706152-Week Range$5.1480 - $11.25Volume65,954 shsAverage Volume36,358 shsMarket Capitalization$499.08 millionP/E RatioN/ADividend YieldN/ABeta0.86 ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada. Receive THERF News and Ratings via Email Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:THERF Previous SymbolNASDAQ:THER CUSIPN/A Webwww.theratech.com Phone514-336-7800 Debt Debt-to-Equity Ratio1.38 Current Ratio2.89 Quick Ratio2.52 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$32.93 million Price / Sales15.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book14.75 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-14,170,000.00 Net Margins-17.11% Return on Equity-17.75% Return on Assets-8.37% Miscellaneous Employees28 Outstanding Shares76,880,000Market Cap$499.08 million OptionableNot Optionable Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions What is Theratechnologies' stock symbol? Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF." How were Theratechnologies' earnings last quarter? Theratechnologies Inc (OTCMKTS:THERF) announced its quarterly earnings results on Thursday, October, 4th. The company reported $0.02 EPS for the quarter. The firm earned $13.53 million during the quarter. Theratechnologies had a negative net margin of 17.11% and a negative return on equity of 17.75%. View Theratechnologies' Earnings History. When is Theratechnologies' next earnings date? Theratechnologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Theratechnologies. What is the consensus analysts' recommendation for Theratechnologies? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Theratechnologies. Has Theratechnologies been receiving favorable news coverage? Media coverage about THERF stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Theratechnologies earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future. Who are some of Theratechnologies' key competitors? Some companies that are related to Theratechnologies include Amicus Therapeutics (FOLD), Endocyte (ECYT), Heron Therapeutics (HRTX), Supernus Pharmaceuticals (SUPN), Pacira Pharmaceuticals (PCRX), Corcept Therapeutics (CORT), Opko Health (OPK), AnaptysBio (ANAB), Ironwood Pharmaceuticals (IRWD), Reata Pharmaceuticals (RETA), Zogenix (ZGNX), Innoviva (INVA), Madrigal Pharmaceuticals (MDGL), PTC Therapeutics (PTCT) and Prestige Consumer Healthcare (PBH). Who are Theratechnologies' key executives? Theratechnologies' management team includes the folowing people: Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 60)Mr. Philippe Dubuc, Sr. VP & CFO (Age 51)Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 50)Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 55)Ms. Lyne Fortin, Sr. VP & Chief Commercial Officer (Age 58) How do I buy shares of Theratechnologies? Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Theratechnologies' stock price today? One share of THERF stock can currently be purchased for approximately $6.4918. How big of a company is Theratechnologies? Theratechnologies has a market capitalization of $499.08 million and generates $32.93 million in revenue each year. Theratechnologies employs 28 workers across the globe. What is Theratechnologies' official website? The official website for Theratechnologies is http://www.theratech.com. How can I contact Theratechnologies? Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected] MarketBeat Community Rating for Theratechnologies (OTCMKTS THERF)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 60 (Vote Outperform)Underperform Votes: 61 (Vote Underperform)Total Votes: 121MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe THERF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THERF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/16/2018 by MarketBeat.com StaffFeatured Article: What is a conference call?